Non-inhibitory chaperone - Relay Therapeutics
Latest Information Update: 03 Jul 2024
Price :
$50 *
At a glance
- Originator Relay Therapeutics
- Class Pharmacological chaperones
- Mechanism of Action Alpha-galactosidase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Fabry's disease